SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-028542
Filing Date
2018-11-08
Accepted
2018-11-08 16:07:51
Documents
84
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tbio-10q_20180930.htm 10-Q 2376844
2 EX-31.1 tbio-ex311_11.htm EX-31.1 14443
3 EX-31.2 tbio-ex312_10.htm EX-31.2 14370
4 EX-32.1 tbio-ex321_9.htm EX-32.1 6122
5 EX-32.2 tbio-ex322_8.htm EX-32.2 6342
  Complete submission text file 0001564590-18-028542.txt   9080758

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT tbio-20180930.xml EX-101.INS 1892890
7 XBRL TAXONOMY EXTENSION SCHEMA tbio-20180930.xsd EX-101.SCH 73998
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tbio-20180930_cal.xml EX-101.CAL 40384
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tbio-20180930_def.xml EX-101.DEF 299386
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE tbio-20180930_lab.xml EX-101.LAB 536838
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tbio-20180930_pre.xml EX-101.PRE 462655
Mailing Address 29 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 29 HARTWELL AVENUE LEXINGTON MA 02421 617-945-7361
Translate Bio, Inc. (Filer) CIK: 0001693415 (see all company filings)

IRS No.: 611807780 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38550 | Film No.: 181169731
SIC: 2836 Biological Products, (No Diagnostic Substances)